You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NK/T-cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Loneliness Trial in Poriyya (Patient-tailored intervention)

Recruiting
  • Loneliness
  • Patient-tailored intervention
  • Poriyya, Israel
    Baruch Padeh (Poriya) Medical Center
Feb 28, 2023

Advanced Solid Tumors Trial in Shanghai (HRXG-K-1939, Adebrelimab)

Not yet recruiting
  • Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 4, 2023

Malaria Trial in Baltimore (VRC-MALMAB0100-00-AB, CHMI)

Completed
  • Malaria
  • Baltimore, Maryland
    University of Maryland Baltimore, Center for Vaccine Development
Nov 9, 2022

NSCLC, Stereotactic Body Radiotherapy, Comprehensive Geriatric Assessment Trial in Denmark (Comprehensive Geriatric Assessment)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Comprehensive Geriatric Assessment
  • Aarhus, Aarhus N, Denmark
  • +3 more
Jun 22, 2023

Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)

Recruiting
  • Sickle Cell Disease
  • Chicago, Illinois
    University of Illinois at Chicago
Oct 21, 2021

Hematopoietic Stem Cell Transplant Trial in Cincinnati (12-16 hour nutrition)

Active, not recruiting
  • Hematopoietic Stem Cell Transplant
  • 12-16 hour nutrition
  • Cincinnati, Ohio
    Cincinnati Children's Hospital
Oct 14, 2022

NSCLC, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Nintedanib)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Stony Brook, New York
  • +27 more
Aug 11, 2022

Infertility, Female, of Uterine Origin, Endometrial Fibrosis Trial in Nanjing (CBD-bFGF, Collagen/BMMNCs, Estrogen)

Recruiting
  • Infertility, Female, of Uterine Origin
  • Endometrial Fibrosis
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Sep 27, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Advanced Solid Tumors or Lymphomas Trial in Worldwide (CA-170)

Completed
  • Advanced Solid Tumors or Lymphomas
  • San Francisco, California
  • +19 more
Jun 24, 2020

NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer NSCLC
  • Bonita Springs, Florida
  • +67 more
Nov 15, 2022

NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

Completed
  • Non-small Cell Lung Cancer
  • Melbourne, Victoria, Australia
  • +1 more
May 23, 2022

PD-1 Antibody Plus Chemotherapy for TKI Failure Driver Gene

Recruiting
  • Non Small Cell Lung Cancer
    • Changsha, Hunan, China
      Yongchang Zhang
    Mar 9, 2022

    NSCLC Trial in Worldwide (FKB238 (bevacizumab), Avastin (bevacizumab), Paclitaxel)

    Completed
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • FKB238 (bevacizumab)
    • +3 more
    • Fountain Valley, California
    • +146 more
    Feb 25, 2022

    Lymphoma, B-Cell Trial in San Antonio (Roflumilast)

    Active, not recruiting
    • Lymphoma, B-Cell
    • San Antonio, Texas
      Mays Cancer Center, UT Health San Antonio
    Mar 9, 2022

    Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

    Not yet recruiting
    • Elderly Patients
    • Metastatic Lung Cancer
    • Single drug chemotherapy plus immunotherapy
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Sep 15, 2023

    Esophageal Squamous Cell Carcinoma Trial in Anyang, Zhengzhou (AK104, nab-paclitaxel, carboplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • AK104, nab-paclitaxel, carboplatin
    • Anyang, Henan, China
    • +1 more
    Jun 1, 2023

    Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)

    Recruiting
    • Lymphoma, B-Cell
    • Chronic Lymphocytic Leukemia
    • Chicago, Illinois
    • +8 more
    Jun 21, 2022

    Sickle Cell Disease, Sickle Cell Trait Trial in Gainesville (CHOICES, eBook)

    Recruiting
    • Sickle Cell Disease
    • Sickle Cell Trait
    • CHOICES
    • eBook
    • Gainesville, Florida
      University of Florida
    May 31, 2022

    Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

    Recruiting
    • Metastatic Colorectal Cancer
    • +4 more
    • Young TIL
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Solid Tumors Trial (GS-9911, Zimberelimab)

    Not yet recruiting
    • Solid Tumors
    • (no location specified)
    Oct 9, 2023

    Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

    Recruiting
    • Solid Tumor
    • +4 more
    • Gilbert, Arizona
    • +4 more
    Aug 4, 2023

    Non Small Cell Lung Cancer, Lung Cancer, Nsclc Trial in United States (Radiation Therapy, Durvalumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Miami, Florida
    • +8 more
    Mar 30, 2022